Tower Research Capital LLC (Trc) Geo Vax Labs, Inc. Transaction History

Tower Research Capital LLC (Trc)

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.3 - $0.57 $71 - $136	-239 Reduced 2.28%	10,265 $3,000
Q3 2023 Nov 14, 2023	SELL	$0.51 - $0.62 $29 - $35	-58 Reduced 0.55%	10,504 $5,000
Q2 2023 Aug 14, 2023	SELL	$0.55 - $0.75 $106 - $145	-194 Reduced 1.8%	10,562 $5,000
Q1 2023 May 09, 2023	BUY	$0.62 - $1.11 $2,535 - $4,538	4,089 Added 61.33%	10,756 $7,000
Q4 2022 Feb 10, 2023	BUY	$0.55 - $17.1 $3,557 - $110,619	6,469 Added 3267.17%	6,667 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.4 - $58.5 $24,475 - $3.58 Million	-61,188 Reduced 99.68%	198 $0
Q2 2022 Aug 15, 2022	BUY	$9.29 - $34.8 $516,059 - $1.93 Million	55,550 Added 951.85%	61,386 $51,000
Q1 2022 May 12, 2022	BUY	$17.25 - $58.95 $100,671 - $344,032	5,836 New	5,836 $7,000
Q4 2021 Feb 14, 2022	SELL	$52.65 - $71.7 $68,602 - $93,425	-1,303 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$56.4 - $91.35 $43,089 - $69,791	764 Added 141.74%	1,303 $6,000
Q2 2021 Aug 16, 2021	SELL	$64.8 - $94.5 $116,964 - $170,572	-1,805 Reduced 77.01%	539 $3,000
Q1 2021 May 17, 2021	BUY	$49.05 - $126.6 $114,973 - $296,750	2,344 New	2,344 $10,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $73M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.